You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Suppliers and packagers for generic pharmaceutical drug: ZILEUTON


✉ Email this page to a colleague

« Back to Dashboard


ZILEUTON

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Annora Pharma ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 215742 ANDA Camber Pharmaceuticals, Inc. 31722-044-12 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-044-12) 2022-10-11
Annora Pharma ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 215742 ANDA NorthStar RxLLC 72603-246-01 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72603-246-01) 2024-05-01
Rising ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 204929 ANDA Rising Pharma Holdings, Inc. 64980-206-12 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12) 2017-03-21
Strides Pharma Intl ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 212670 ANDA Golden State Medical Supply, Inc. 51407-741-12 120 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (51407-741-12) 2019-12-16
Strides Pharma Intl ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 212670 ANDA Strides Pharma Science Limited 64380-189-01 120 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (64380-189-01) 2022-10-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Zileuton

Last updated: July 28, 2025

Introduction

Zileuton is a leukotriene synthesis inhibitor primarily used in the management of asthma. Manufactured by GSK under the brand name Zyflo, it inhibits 5-lipoxygenase, reducing leukotriene production, thereby alleviating airway inflammation and bronchoconstriction. As a specialized therapeutic, the supply chain for Zileuton involves a range of suppliers spanning raw materials, active pharmaceutical ingredients (APIs), intermediates, and packaging components. Understanding these suppliers is critical for pharmaceutical companies, healthcare providers, and investors aiming to ensure drug availability, compliance, and cost efficiency.

Overview of Zileuton's Manufacturing Process

The manufacturing of Zileuton involves complex chemical synthesis, requiring high purity raw materials and stringent quality control. The process predominantly uses specific aromatic compounds, heterocyclic intermediates, and catalysts to produce the API. The key steps include chlorination, oxidation, cyclization, and purification phases (as detailed in manufacturing patents and scientific literature). These steps translate into the need for specialized suppliers of chemical intermediates, catalysts, solvents, and analytical reagents.

Raw Material Suppliers

Aromatic and Heterocyclic Precursors

Zileuton's synthesis begins with aromatic compounds like benzene derivatives and heterocyclic intermediates such as pyridinone derivatives. Suppliers for these raw materials include global chemical producers with robust compliance standards:

  • BASF: Supplies various aromatic chemicals and heterocyclic intermediates used in pharmaceutical synthesis, known for high purity standards.
  • Dow Chemical: Provides a broad portfolio of specialty chemicals suitable for API manufacturing.
  • Sigma-Aldrich (Merck): Offers pharmaceutical-grade chemicals and custom synthesis services, including heterocyclic compounds.

Catalysts and Solvents

Catalysts such as molybdenum and iron compounds are vital during oxidation and cyclization steps. Solvents like acetonitrile, dichloromethane, and ethanol are essential for reaction processes:

  • Sigma-Aldrich: Supplies pharmaceutical-grade solvents.
  • TCI Chemicals: Provides specialty catalysts and reagents used in organic synthesis.

Active Pharmaceutical Ingredient (API) Suppliers

Original Manufacturer: GlaxoSmithKline (GSK)

GSK is the primary patent holder and manufacturer of Zileuton with established production facilities, ensuring consistent quality and supply. The patent expiration and generic manufacturing diversifications have led to a global shift toward third-party API suppliers.

Generic API Manufacturers

Post-patent expiry, several generic firms have entered the market, sourcing APIs from external suppliers or producing in-house under licensed conditions:

  • Hetero Labs (India): Known for manufacturing high-quality APIs, including Zileuton, leveraging integrated supply chains for raw materials and intermediates.
  • Kangtai Pharmaceutical (China): Supplies Zileuton API, with compliance to Good Manufacturing Practices (GMP).
  • Mylan (now part of Viatris): Involved in generic drug production, potentially sourcing Zileuton API from multiple manufacturing sites.
  • Dr. Reddy’s Laboratories: Occasionally quotes APIs for internal use and third-party supply.

Manufacturers often operate under stringent regulatory oversight to comply with US FDA, EMA, and other agencies' standards, ensuring API purity, potency, and stability.

Contract Manufacturing Organizations (CMOs)

To meet global demand, pharmaceutical companies often outsource API and formulation processes to CMOs:

  • Aenova Group (Germany): Provides CMO services for API synthesis and finished product manufacturing.
  • Laurus Labs (India): Equipped for complex chemical synthesis, including leukotriene inhibitors.
  • Piramal Pharma Solutions (India): Offers API manufacturing with a focus on process optimization and quality.

Regulatory and Compliance Considerations

Suppliers must adhere to GMP, Food and Drug Administration (FDA) approvals, and international standards. Due diligence involves assessing their manufacturing capabilities, quality control measures, and traceability.

Packaging and Distribution Components

Secondary suppliers for packaging (blister packs, glass bottles) and distribution logistics are essential for maintaining drug stability and compliance, with providers like Schott, Gerresheimer, and Corning supplying specialized materials.

Geographic Distribution of Suppliers

  • India and China: Leading producers of generic APIs and intermediates due to cost advantages and manufacturing capacity.
  • Europe and North America: Focus on high-purity raw materials, catalysts, and packaging components, compliant with regulatory standards.

Market Trends Influencing Supplier Dynamics

The decline of patent protections for Zileuton has increased the number of suppliers, driving competition and price reductions. Concurrently, regulatory scrutiny encourages the consolidation of high-quality suppliers and investment in supply chain resilience.

Conclusion

The supply chain for Zileuton encompasses an array of global suppliers specializing in raw materials, intermediates, APIs, and packaging components. Key players include major chemical companies like BASF and Sigma-Aldrich, Indian generic manufacturers such as Hetero Labs and Laurus Labs, and CMOs facilitating process scalability. Ensuring robust oversight and diversified sourcing strategies remains essential for continuous supply, quality assurance, and regulatory compliance.


Key Takeaways

  • Diversify sourcing: To mitigate supply risks, pharmaceutical companies should engage multiple qualified suppliers across different geographies.
  • Prioritize quality compliance: All suppliers must meet GMP and international regulatory standards to ensure API safety and efficacy.
  • Monitor market trends: Patent expirations and market competition influence supplier dynamics and pricing.
  • Invest in supply chain resilience: Strategic partnerships with established CMOs and raw material suppliers provide flexibility and stability.
  • Leverage technological advancements: Innovations in chemical synthesis and process optimization can reduce costs and improve supply consistency.

FAQs

1. Who are the main suppliers of Zileuton API globally?
Primary sources include original manufacturers like GSK, with generic production by firms such as Hetero Labs (India), Kangtai Pharma (China), and other regional contract manufacturers.

2. Are raw material suppliers for Zileuton interchangeable?
While some raw materials can be sourced from multiple suppliers, strict quality standards and regulatory approvals limit interchangeability, necessitating careful qualification.

3. How does patent expiry influence supplier options for Zileuton?
Patent expiration allows multiple generic manufacturers to produce Zileuton, expanding the supplier pool and promoting competitive pricing and supply diversification.

4. What role do CMOs play in Zileuton production?
CMOs handle complex synthesis steps, scale-up, and finished formulation manufacturing, providing flexibility and capacity to meet global demand.

5. What are the key regulatory considerations for Zileuton suppliers?
Suppliers must comply with GMP, FDA, EMA, and other international quality standards, ensuring consistent purity, potency, and batch traceability.


Sources
[1] Patent and scientific literature on Zileuton manufacturing processes.
[2] GSK product information and patent details.
[3] Chemical supplier catalogs and GMP compliance standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.